Market Introduction
Escherichia coli (E. coli) are rod-shaped gram-negative bacteria. These bacteria are the leading cause of diarrheal diseases, especially among children primarily through food or drinking water contaminated with animal or human feces. Some strains of the E. coli bacteria produce Shiga toxin that causes gastrointestinal (GI) infections and medical complications like gastrointestinal tract infections, cholangitis, cholecystitis, bacteremia, neonatal meningitis and pneumonia, urinary tract infection (UTI). This syndrome, if untreated, can result in harmful results such as kidney failure. E. coli tests are used to diagnose GI infections using stool samples. These tests can be performed using molecular diagnostic kits and immunoassays.
Market Overview and Dynamics
The North AmericaE. colitestingmarket is to reach US$ 1,165.0 Mn by 2027 from US$ 680.9 Mn in 2019. The market is anticipated to grow at a CAGR of 7.1% during 2019–2027.Factors such as the rise in E. coli testing, growing product innovation, and rising research activities are expected to boost the growth of the E. colitesting market. However, the market is likely to get impacted by the risk factor such as testing challenges during the forecast period.
Key Market Segments
In terms of technology, the monoclonal antibodies segment accounted for the largest share of the North America E. colitestingmarket in 2019. The public health labs segment accounted for the largest share of the North America E. colitestingmarket, by end-user, in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the North America E. colitestingmarket report are theWorld Health Organization (WHO), Centers of Disease Control and Prevention (CDC),OECD Health Statistics, andothers.
Reasons to buy report
NORTH AMERICA E. COLITESTINGMARKET SEGMENTATION
By Technology
By End-User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 680.9 Million |
| Market Size by 2027 | US$ 1,165.0 Million |
| CAGR (2019 - 2027) | 7.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America E. coli Testing Market is valued at US$ 680.9 Million in 2019, it is projected to reach US$ 1,165.0 Million by 2027.
As per our report North America E. coli Testing Market, the market size is valued at US$ 680.9 Million in 2019, projecting it to reach US$ 1,165.0 Million by 2027. This translates to a CAGR of approximately 7.1% during the forecast period.
The North America E. coli Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America E. coli Testing Market report:
The North America E. coli Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America E. coli Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America E. coli Testing Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America E. coli Testing Market
